SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Clough C. Restless legs syndrome. Br Med J. 1987;294:2623.
  • 2
    Rama AN, Kushida CA. Restless legs syndrome and periodic limb movement disorder. Med Clinics N Am. 2004;88:65367.
  • 3
    Hening WA, Allen RP, Earley CJ, Picchietti DL, Silber MH. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 2004;27:56083.
  • 4
    Earley CJ. Restless legs syndrome. N Engl J Med. 2003;348:21039.
  • 5
    Silber MH, Ehrenberg BL, Allen RP, et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc. 2004;79:91622.
  • 6
    Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol. 2005;4:46575.
  • 7
    Happe S, Klösch G, Saletu B, Zeitlhofer J. Treatment of idiopathic restless legs syndrome (RLS) with gabapentine. Neurology. 2001;57:17179.
  • 8
    Garcia-Borreguero D, Larrosa O, De La Llave Y, Verger K, Marsramon X, Hernandez G. Treatment of restless legs syndrome with gabapentine: a double-blind, cross-over study. Neurology. 2002;59:15739.
  • 9
    O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing. 1994;23:2003.
  • 10
    Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep. 1996;19:20513.
  • 11
    Guilleminault C, Cetel M, Philip P. Dopaminergic treatment of restless legs syndrome and rebound phenomenon. Neurology. 1993;43:445.
  • 12
    Collado-Seidel V, Kazenwadel J, Wetter TC, et al. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms. Neurology. 1999;52:28590.
  • 13
    Stiasny K, Wetter TC, Trenkwalder C, Oertel WH. Restless legs syndrome and its treatment by dopamine agonists. Parkinsonism Relat Disord. 2001;7:215.
  • 14
    Comella CL. Restless legs syndrome: treatment with dopaminergic drugs. Neurology. 2002;58:S87S92.
  • 15
    Winkelman JW, Johnston L. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep Med. 2004;5:914.
  • 16
    Garcia-Borreguero D, Lee D, Ball E. Ropinirole is well tolerated and effective for the long-term treatment of RLS. Neurology. 2005;64:A42.
  • 17
    Vetrugno R, Contin M, Baruzzi A, et al. Polysomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless leg syndrome. Mov Disord. 2006;21:2548.
  • 18
    Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry. 2004;75:927.
  • 19
    Walters AS, Ondo WG, Dreykluft T, et al. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord. 2004;19:141423.
  • 20
    Bogan RK, Fry JM, Schmidt MH, et al. Ropinirole in the treatment of patients with restless legs syndrome: a U.S.-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc. 2006;81:1727.
  • 21
    Bliwise DL, Freeman A, Ingram CD, et al. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome. Sleep Med. 2005;6:1417.